openPR Logo
Press release

H1 Myocardial Infarction Therapeutics Market Pipeline Analysis Report 2017

05-26-2017 07:52 AM CET | Health & Medicine

Press release from: Reports and Reports

H1 Myocardial Infarction Therapeutics Market Pipeline

Global industry analysis on Myocardial Ischemia pipeline market report and opportunity assessment H1 report provides comprehensive information on the therapeutics under development for Myocardial Ischemia (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Complete report @ http://www.reportsnreports.com/reports/1010746-myocardial-ischemia-pipeline-review-h1-2017.html

Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side of the body (angina pectoris), neck or jaw pain, shoulder or arm pain, clammy skin, shortness of breath and nausea and vomiting. Myocardial ischemia can be caused by conditions such as coronary artery disease (atherosclerosis), blood clot, coronary spasm and severe illnesses. The factors that may increase the risk of developing myocardial ischemia include tobacco, diabetes, high blood pressure, high blood cholesterol or triglyceride levels, lack of physical activity, obesity and family history.

Myocardial Ischemia pipeline companies are Angionetics Inc, Bayer AG, Cellmid Ltd, CohBar Inc, Lixte Biotechnology Holdings Inc, NoNO Inc, Omniox Inc, Pathfinder Cell Therapy Inc, Shire Plc, Symic Biomedical Inc, ViroMed Co Ltd.

Drug Profiles of Myocardial Ischemia AB-002, alferminogene tadenovec, AntimiR-199a, BAY-606583, CMK-103, EP-80317, Humanin, LB-100, OMX-4.80, Pathfinder Cells, Peptagon, PMC-6, SB-030, Disorders more..

Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1010746 (This report is available at upto 25% Discount till June 02nd 2017.)

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Myocardial Ischemia (Cardiovascular).
- The pipeline guide reviews pipeline therapeutics for Myocardial Ischemia (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Myocardial Ischemia (Cardiovascular) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Myocardial Ischemia (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Myocardial Ischemia (Cardiovascular)

Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=1010746

List of Tables
Number of Products under Development for Myocardial Ischemia, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Myocardial Ischemia - Pipeline by Angionetics Inc, H1 2017
Myocardial Ischemia - Pipeline by Bayer AG, H1 2017
Myocardial Ischemia - Pipeline by Cellmid Ltd, H1 2017
Myocardial Ischemia - Pipeline by CohBar Inc, H1 2017
Myocardial Ischemia - Pipeline by Lixte Biotechnology Holdings Inc, H1 2017
Myocardial Ischemia - Pipeline by NoNO Inc, H1 2017
Myocardial Ischemia - Pipeline by Omniox Inc, H1 2017
Myocardial Ischemia - Pipeline by Pathfinder Cell Therapy Inc, H1 2017
Myocardial Ischemia - Pipeline by Shire Plc, H1 2017
Myocardial Ischemia - Pipeline by Symic Biomedical Inc, H1 2017
Myocardial Ischemia - Pipeline by ViroMed Co Ltd, H1 2017
Myocardial Ischemia - Dormant Projects, H1 2017
Myocardial Ischemia - Discontinued Products, H1 2017

About Us:
ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help in purchase decision by mapping your information needs with our huge collection of reports.

2nd floor, metropole,
Next to inox theatre,
Bund garden road,
Pune-411001.
+ 1 888 391 5441
sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release H1 Myocardial Infarction Therapeutics Market Pipeline Analysis Report 2017 here

News-ID: 552416 • Views: 312

More Releases from Reports and Reports

World Diamond Jewelry Market Research Report 2015-2023
World Diamond Jewelry Market report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data. Global World Diamond Jewelry Market, provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The World Diamond Jewelry Market analysis is provided for the international Industry including development trends, competitive landscape analysis,
Global Gaucher Disease Treatment Industry Market Share Analysis Report 2017
Report on Global Gaucher Disease Treatment Industry Market With the valuation from the year 2017 to 2022 Based on the Gaucher Disease Treatment industrial chain, this report mainly elaborate the definition, types, applications and major players of Gaucher Disease Treatment market in details. Deep analysis about market status (2012-2017), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2017-2022), regional industrial layout characteristics and macroeconomic policies, industrial policy has
Global Electric Seats Market Research Report 2017
Reports on Global Electric Seats Market With the valuation from the year 2017 to 2022 Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Eye Wash Station in these regions, from 2012 to 2022 (forecast), The reports was drawn considering the following regions. North America Europe China Japan Southeast Asia India Global Elect  GET A SAMPLE REPORT @ https://www.reportsmonitor.com/request-sample/?post=386158  Global Electric Seats Market research report as also taken into
Global IoT Microcontroller Market Expected to Grow at 16.06% CAGR to 2024
The leading players of the IoT Microcontroller market are Fujitsu, Atmel, Holtek, Infineon, Ixys Corporation, Renesas, Spansion, Texas Instruments, St Microelectronics, Microchip, Nuvoton, Nxp, Samsung. Complete report at http://www.reportsnreports.com/reports/1151616-global-internet-of-things-microcontroller-market-forecast-2017-2024.html The IoT Microcontroller Market estimated to expand from $1977 million in 2016 to $6490 million by 2024, at a CAGR of 16.06% during the forecast period. Expansion of internet of things market and increasing demand for automation across end-user industries are the primary

All 5 Releases


More Releases for Myocardial

Post-Myocardial Infarction Market rake higher revenue in 2025
Global Post-Myocardial Infarction Market: Overview The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are
Post-Myocardial Infarction Market Discerning new trends 2025
Global Post-Myocardial Infarction Market: Overview The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are
Myocardial Ischemia Market to Record Ascending Growth
Myocardial ischemia is characterized by a specific condition, where there is an insufficient flow of blood to the heart muscle (myocardium) through coronary arteries. Due to an obstruction or constriction of the arteries, the heart is not able to pump oxygenated blood and other vital nutrients to the body efficiently and finally leads to destruction of the heart muscles. Blockage of an artery (due to atherosclerotic plaque), blood clots, heart
Post-Myocardial Infarction Market - Vendor Landscape & Forecast 2017 - 2025
Global Post-Myocardial Infarction Market: Overview The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are
Myocardial Ischemia Therapeutics Pipeline Analysis - Clinical Trials , Results, …
Myocardial ischemia is a cardiovascular disorder that causes angina, shortness of breath and cardiac arrhythmias. Myocardial ischemia is one of the reasons of the sudden cardiac death. Due to obstruction of coronary blood flow, oxygen and glucose flow is interrupted that causes impairment of cellular metabolism. In an electrocardiogram, the ST-segment depression is observed as the clinical sign of myocardial ischemia. Access Report Overview: https://www.psmarketresearch.com/market-analysis/myocardial-ischemia-therapeutics-pipeline-analysis Myocardial ischemia can be diagnosed by
Myocardial Infarction - Market Insights, Epidemiology and Market Forecast-2023
"The Report Myocardial Infarction - Market Insights, Epidemiology and Market Forecast-2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​DelveInsights Myocardial Infarction - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Myocardial Infarction for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. Get